Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M699Revenue $M5.6Net Margin (%)-1,811.7Altman Z-Score15.7
Enterprise Value $M479EPS $-3.4Operating Margin %-1,782.0Piotroski F-Score4
P/E(ttm)--Beneish M-Score-1.4Pre-tax Margin (%)-1,811.7Higher ROA y-yY
Price/Book3.310-y EBITDA Growth Rate %-12.1Quick Ratio11.4Cash flow > EarningsY
Price/Sales1015-y EBITDA Growth Rate %-3.8Current Ratio11.4Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-68.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-87.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M38.4ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with DVAX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DVAXGeorge Soros 2012-06-30 Sold Out -0.03%$35.2 - $52.6
($42.76)
$ 18.20-57%Sold Out0
DVAXGeorge Soros 2012-03-31 Reduce-0.09%$32.8 - $50.3
($40.41)
$ 18.20-55%Reduce -62.50%37,500
DVAXGeorge Soros 2011-12-31 Buy 0.14%$18.2 - $33.3
($28.15)
$ 18.20-35%New holding100,000
DVAXGeorge Soros 2011-09-30 Sold Out -0.0026%$18.4 - $31.6
($24.39)
$ 18.20-25%Sold Out0
DVAXGeorge Soros 2011-06-30 Buy 0.0026%$24.6 - $28.1
($26.35)
$ 18.20-31%New holding6,610
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DVAX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


DVAX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Janssen RobertVice President 2015-10-08Buy100$23.34-19.32view
Gray EddieCEO and Director 2014-08-14Buy2,500$14.926.38view
KISNER DANIEL LDirector 2013-10-30Buy1,000$10.874.35view
ORONSKY ARNOLD LDirector 2013-10-30Buy18,605$10.874.35view
Phillips Peggy VDirector 2013-10-30Buy9,302$10.874.35view
Janssen RobertChief Medical Officer and VP 2013-07-09Sell0$074.35view
Novack David FSenior Vice President 2013-03-25Sell0$074.35view
COFFMAN ROBERTChief Scientific Officer & VP 2012-11-06Sell800$43.1-56.31view
KESSEL MARKDirector 2012-10-16Sell600,000$47.3-60.19view
COFFMAN ROBERTChief Scientific Officer & VP 2012-10-05Sell800$49.4-61.88view

Press Releases about DVAX :

Quarterly/Annual Reports about DVAX:

News about DVAX:

Articles On GuruFocus.com
William Blair’s Top BioPharmaceutical Stock Picks for Q1 2015 Dec 23 2014 
Two Promising Health Care Stocks with Market Capitalizations Under $500 Million Jun 11 2014 
Top Three Largest Insider Buys of the Past Week Nov 05 2013 
Steven Cohen, George Soros, John Paulson All Add to Holdings Mar 07 2012 
Dynavax Technologies Corp. Reports Operating Results (10-Q) Aug 02 2010 
Dynavax Technologies Corp. Reports Operating Results (10-Q) May 10 2010 
Price % Loser Stocks of The Day: SIGA Technologies Inc., Universal Travel Group, U.S. Concrete Inc., Dec 10 2009 
Dynavax Technologies Corp. Reports Operating Results (10-Q) Oct 30 2009 
Dynavax Technologies Corp. Reports Operating Results (10-Q) Aug 06 2009 
Dynavax Technologies Corp. Reports Operating Results (10-Q) Apr 30 2009 

More From Other Websites
Dynavax Technologies Corp. breached its 50 day moving average in a Bullish Manner : January 25, 2016 Jan 25 2016
Strength Seen in Dynavax (DVAX): Stock Gains 11.1% Jan 25 2016
DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Jan 20 2016
Dynavax, AstraZeneca Amend Deal for Asthma Candidate Jan 20 2016
Dynavax and AstraZeneca Amend Their Agreement for Asthma Drug Candidate Jan 19 2016
The Zacks Analyst Blog Highlights: Baxalta, Juno, Horizon Pharma, AbbVie and Dynavax Jan 14 2016
Biotech Stock Roundup: Baxalta - Shire to Combine, JPM Healthcare Conference in Focus Jan 13 2016
Dynavax Technologies Corp. breached its 50 day moving average in a Bearish Manner : January 12, 2016 Jan 12 2016
Dynavax to Present at J.P. Morgan 34th Annual Healthcare Conference Jan 11 2016
Dynavax's Heplisav-B Tops GlaxoSmithKline's Engerix-B Jan 08 2016
Dynavax Technologies (DVAX) Catches Eye: Stock Up 40.2% Jan 08 2016
DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jan 07 2016
Why #JPM16 matters: Biotechs open news spigots ahead of big conference Jan 07 2016
Dynavax Hepatitis B Vaccine Beats Glaxo's In Trial Jan 07 2016
Dynavax Hepatitis B Vaccine Beats Glaxo's In Trial Jan 07 2016
Dynavax Soars on Positive Late Stage Results Jan 07 2016
Why Are Investors Bullish On These Five Stocks On Thursday? Jan 07 2016
Dynavax's hep B vaccine meets goals in late-stage study Jan 07 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK